Haemonetics Corp. (HAE)

Haemonetics (HAE) Income Statement


Haemonetics Income Statement

Last quarter (Q ), Haemonetics's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q, Haemonetics's net income was $―. See Haemonetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Apr 23Apr 22Mar 22Mar 21Mar 20
Total Revenue
$ 864.24M$ 1.17B-$ 993.20M$ 870.46M$ 988.48M
Cost of Revenue
$ 112.21M$ 553.56M$ 487.69M$ 487.69M$ 472.63M$ 503.97M
Gross Profit
$ 458.85M$ 615.10M$ -487.69M$ 505.50M$ 397.84M$ 484.51M
Operating Expense
$ 107.60M$ 459.06M$ 433.78M$ 433.78M$ 339.88M$ 338.65M
Operating Income
$ 120.40M$ -1.01B$ -921.47M$ 71.72M$ 57.96M$ 145.87M
Net Non Operating Interest Income Expense
$ -10.95M$ 13.00M$ 5.80M$ -17.12M$ -16.83M$ -16.20M
Other Income Expense
$ 1.44M$ -1.15B$ -985.10M$ 9.03M$ 31.78M$ -42.52M
Pretax Income
$ 108.78M$ 141.40M$ 63.63M$ 63.63M$ 72.91M$ 87.15M
Tax Provision
$ 22.78M$ 26.00M$ 20.30M$ 20.25M$ -6.56M$ 10.63M
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ 86.00M$ 115.40M$ 43.33M$ 43.38M$ 79.47M$ 76.53M
Basic EPS
$ 1.69$ 2.27$ 0.85$ 0.85$ 1.57$ 1.51
Diluted EPS
$ 1.66$ 2.24$ 0.84$ 0.84$ 1.55$ 1.48
Basic Average Shares
$ 152.69M$ 50.78M$ 51.05M$ 51.05M$ 50.69M$ 50.69M
Diluted Average Shares
$ 154.46M$ 51.42M$ 51.35M$ 51.35M$ 51.29M$ 51.81M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
$ 1.41---$ 2.35$ 3.31
Rent Expense Supplemental
Total Expenses
$ 219.80M$ 1.01B$ 921.47M$ 921.47M$ 812.50M$ 842.61M
Net Income From Continuing And Discontinued Operation
$ 86.00M$ 115.40M$ 43.33M$ 43.38M$ 79.47M$ 76.53M
Normalized Income
$ 52.76M--$ 37.22M$ 56.27M$ 113.86M
Interest Expense
$ 10.95M--$ 17.12M$ 16.83M$ 16.20M
$ 119.72M$ 128.40M$ 57.83M$ 80.75M$ 89.75M$ 103.35M
$ 173.68M$ 35.10M$ -39.92M$ 178.50M$ 174.03M$ 213.64M
Currency in USD

Haemonetics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis